Domestic pharmaceutical retail market grows 11 per cent in July

The domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain relief due to rising flu and viral infections. Antibiotic Augmentin led sales at Rs 72 crore and topped the charts. Overall market valued at Rs 2,22,906 crore, showing 7 per cent growth in June. Sun Pharma maintained a top position, with Indian companies growing at 11.4 per cent and MNCs at 10.2 per cent in July. Analysts predict a 10 per cent growth driven by demand for acute therapies like anti-infectives.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vSwthmb
via IFTTT